Tag: TCAR
InspireMD receives IDE approval from US FDA for CGUARDIANS II pivotal...
InspireMD has announced US Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II pivotal...
Silk Road celebrates milestone of 100,000 TCAR procedures
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date.
“A growing number of...
CEA and TCAR should be “first-line” interventions for weekend carotid revascularisation,...
Patients who undergo carotid revascularisation at the weekend have increased odds of complications and mortality, with transfemoral carotid artery stenting (TFCAS) posing the highest...
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes...
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable...
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and...
High stroke and death rates relating to carotid stenting in the Pacific Northwest of the USA may be driven by the selection of high-risk...
Boston Scientific announces agreement to acquire Silk Road Medical
Boston Scientific has announced that it has entered into a definitive agreement to acquire Silk Road Medical, a medical device company involved in producing...
CEA versus TCAR: surgeons should be familiar with both procedures and...
When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularisation (TCAR) in the treatment of carotid artery stenosis, operators...
Silk Road adds Enroute NPS Plus device to TCAR portfolio
Silk Road Medical has announced the launch of its Enroute transcarotid neuroprotection system Plus (NPS Plus), which the company describes as a key component of...
Single-centre analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-centre analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...
Silk Road expands TCAR portfolio with launch of tapered Enroute system
Silk Road Medical has announced the launch of its tapered Enroute transcarotid stent system to hospitals in the USA, expanding upon the company’s prior...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA) hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
CX 2024: New technologies and “special cases” underpin carotid and acute...
With a renewed focus on challenging cases, novel technologies and, overall, the most pressing issues in carotid treatments and acute stroke care, the 2024...
Rates of stroke, death and myocardial infarction post-TCAR do not differ...
While sex disparities regarding the outcomes of carotid revascularisation have “long been a concern”, new prospective data published in the Journal of Vascular Surgery...
Carotid endarterectomy associated with less reintervention than stenting in first six...
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA...
Safety benefits mean TCAR may be preferable approach in radiation-induced carotid...
A study presented recently at the Vascular Annual Meeting (VAM; 14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery...
More research needed but lithotripsy plus TCAR ‘an answer’ in certain...
Earlier this year, researchers debuted single-centre experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularisation (TCAR) into patients with...
Vascular community split over “death” of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—on...
Initial cases indicate lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
DAPT at discharge reduces stroke and mortality risk versus other drug...
A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT),...
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
Analysis finds no difference in TCAR outcomes between academic and community...
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularisation (TCAR) between academic and...
Endarterectomy and TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularisation, with CEA and transcarotid...
Silk Road Medical announces first patient enrolled in ROADSTER 3 post-approval...
Silk Road Medical has announced enrolment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicentre, single-arm...
Early TCAR results in higher ipsilateral postoperative stroke rates when compared...
Adham Elmously (New York Presbyterian Hospital, New York, USA) presented outcomes of early transcarotid artery revascularisation (TCAR) versus carotid endarterectomy (CEA) after acute neurologic...
Low rate of new white lesions detected after TCAR using diffusion-weighted...
New white lesions are not a common occurrence in patients who have undergone transcarotid artery revascularisation (TCAR), a study in which patients were assessed...
Silk Road to evaluate TCAR in standard surgical risk patients with...
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularisation (TCAR) system in the treatment of standard surgical risk patients...
Silk Road Medical announces expanded Medicare coverage for TCAR in standard...
Silk Road Medical recently announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery’s Patient Safety...
Charing Cross audience as-yet unconvinced by data supporting transcarotid artery revascularisation
Audience polling during the Acute Stroke Challenges session at this year’s Charing Cross Symposium (CX 2022; 26–28 April, London, UK and virtual) revealed scepticism...
New ESVS carotid guidelines: Key questions answered
Clark Zeebregts (University Medical Centre Groningen, Groningen, The Netherlands) and Kosmas Paraskevas (Central Clinic of Athens, Athens, Greece) answer some key questions about the...
Silk Road Medical announces FDA approval of expanded indications for the...
Silk Road Medical recently announced that the US Food and Drug Administration (FDA) approved expanded indications for the company's Enroute stent to include patients...
Worldwide TCAR analysis provides “roadmap” to evaluate future training approaches
An analysis of the worldwide experience of transcarotid artery revascularisation (TCAR) has produced key objective proficiency metrics and an analytic framework to assess adequate...
Expedited carotid artery surgery after index event “probably safer” than expedited...
A systematic review and meta-analysis of 71 studies suggests that, at present, carotid endarterectomy (CEA) is safer than carotid artery stenting (CAS) when performed...
Cost-effectiveness of TCAR versus carotid endarterectomy addressed in new study
A cost-effectiveness model based on peer-reviewed sources suggests that, although five-year costs for transcarotid artery revascularisation (TCAR; Silk Road Medical) were higher than those for...
TCAR yields “high technical success, with an extraordinarily low stroke and...
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularisation (TCAR; Silk Road Medical) treatment for carotid stenosis...
Study detects no difference in adverse outcomes from balloon dilatation strategy...
Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularisation (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery...
TCAR may be associated with favourable outcomes for treatment of restenotic...
Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...
First ever analysis of TCAR in standard surgical risk patients demonstrates...
Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularisation...
Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...
Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients.
Best...
Study finds hospital availability of TCAR associated with an improvement in...
Silk Road Medical has announced positive results from a comparative-effectiveness study have been published in JAMA Network Open.
The study found the availability of TCAR...
